Oral contraceptives and risk of intracranial meningioma: insights from a French nationwide study
Introduction A recent case-control study based on the French National Health Data System (SNDS) assessed the association between the use of progestin-only oral contraceptives and the risk of intracranial meningioma requiring surgery. This large-scale analysis, including more than 92,000 women...
Save the date – KICK OFF Meeting Réseau NeuroDM
SAVE THE DATE – KICK OFF MEETING RÉSEAU NeuroDM Thursday, September 11, 2025🕤 From 9:30 AM to 4:30 PM📍 A unique platform dedicated to medical devices (MD) We are delighted to invite you to the KICK-OFF MEETING of the NeuroDM...
Is Direct Decompression Necessary for Lateral Lumbar Interbody Fusion (LLIF)?
A Randomized Controlled Trial Comparing Direct and Indirect Decompression with LLIF in Selected Patients Objective: To compare clinical and radiological outcomes after lateral lumbar interbody fusion (LLIF), using either direct or indirect decompression, in patients with degenerative lumbar spine diseases....
Pituitary Surgery in Elderly Patients: Is It Safe Beyond 75 Years?
As the global population ages, more elderly patients require surgical interventions, including pituitary surgery. However, data on the safety and effectiveness of pituitary surgery in patients aged 75 and older remain limited. This article explores a recent study evaluating surgical outcomes in this age group,...
Medroxyprogesterone Acetate and Meningioma: A Global Concern
What is Medroxyprogesterone Acetate (DMPA)? Medroxyprogesterone acetate (DMPA) is a widely prescribed injectable progestogen contraceptive used by 74 million women worldwide each year. This contraceptive is particularly valued for its high effectiveness and ease of administration. DMPA is administered as an intramuscular injection (150 mg/ml) or...
Closure Strategy in Endoscopic Pituitary Surgery: Experience from 3,015 Patients
Introduction The closure step in endoscopic pituitary surgery is crucial and requires an effective strategy to minimize postoperative complications. Numerous surgical techniques have been described, but no clear consensus has been established. Methods Between January 2006 and March 2022, 3,015...
Giant Pituitary Tumors: Surgical Outcomes and Management
Introduction Giant pituitary tumors (>40 mm) present a major therapeutic challenge due to the lack of established guidelines. This retrospective study analyzes a large cohort of patients managed by an expert multidisciplinary team, focusing on treatments and postoperative outcomes. Methods...
Pituitary Surgery for Cushing’s Disease: A Comprehensive Overview
Introduction Pituitary surgery is the standard treatment for Cushing’s disease, offering high success rates in well-defined cases. This article explores the surgical approach, challenges, and key considerations to optimize patient outcomes. Surgical Approach For patients with clearly visualized adenomas on pituitary MRI,...
Efficacy of Endoscopic Endonasal Transsphenoidal Surgery for Cushing’s Disease in 230 Patients with Positive and Negative MRI
Introduction Cushing’s disease is a rare endocrine disorder caused by an excess production of cortisol due to a pituitary adenoma. Endoscopic endonasal transsphenoidal surgery (EETS) is the gold standard for tumor removal, but its effectiveness varies depending on MRI findings....
Workshop: Neurosurgery & Cancer Pain
In an effort to enhance the department’s healthcare services, Dr. Caudron participated in the Neurosurgery & Cancer Pain workshop, held in Amiens on February 6 and 7. This workshop, jointly organized by the French Society of Neurosurgery and the French...